Dr. Lal Path Labs · NSE: LALPATHLAB · BSE: 539524
Q2 FY23 results · Jul–Sep 2022
Dr. Lal Path Labs reported revenue from operations of ₹533.80 crore (up 7.1% from Q2 FY22) and net profit of ₹72.40 crore (down 24.8% from Q2 FY22) for Q2 FY23 (Jul–Sep 2022), on a consolidated basis.
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 533.80 | 498.40 | +7.1% | 502.70 | +6.2% |
| Other income | 8.70 | 14.30 | −39.2% | 8.30 | +4.8% |
| Total income | 542.50 | 512.70 | +5.8% | 511.00 | +6.2% |
| Profit before tax | 102.80 | 130.60 | −21.3% | 81.40 | +26.3% |
| Net profit for the period | 72.40 | 96.30 | −24.8% | 58.20 | +24.4% |
| Attributable to shareholders of the company | 71.70 | 95.00 | −24.5% | 57.70 | +24.3% |
| EPS, basic (₹) | 8.64 | 11.49 | −24.8% | 6.97 | +24.0% |
| Net margin (%) | 13.6 | 19.3 | 11.6 |
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 466.90 | 470.40 | −0.7% | 439.30 | +6.3% |
| Other income | 7.60 | 15.30 | −50.3% | 18.80 | −59.6% |
| Total income | 474.50 | 485.70 | −2.3% | 458.10 | +3.6% |
| Profit before tax | 106.40 | 125.90 | −15.5% | 101.70 | +4.6% |
| Net profit for the period | 78.60 | 93.90 | −16.3% | 79.60 | −1.3% |
| EPS, basic (₹) | 9.50 | 11.36 | −16.4% | 9.61 | −1.1% |
| Net margin (%) | 16.8 | 20.0 | 18.1 |
Consolidated
- Filed with BSE
- 09 Nov 2022, 13:11 IST
- Board meeting
- 08 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 09 Nov 2022, 13:11 IST
- Board meeting
- 08 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE